Schmidt M - Search Results

1

Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors.

Schmidt M, Maurer-Gebhard M, Groner B, Köhler G, Brochmann-Santos G, Wels W. Schmidt M, et al. Oncogene. 1999 Mar 4;18(9):1711-21. doi: 10.1038/sj.onc.1202489. Oncogene. 1999. PMID: 10208432

2

Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2.

Azemar M, Djahansouzi S, Jäger E, Solbach C, Schmidt M, Maurer AB, Mross K, Unger C, von Minckwitz G, Dall P, Groner B, Wels WS. Azemar M, et al. Among authors: schmidt m. Breast Cancer Res Treat. 2003 Dec;82(3):155-64. doi: 10.1023/b:brea.0000004371.48757.19. Breast Cancer Res Treat. 2003. PMID: 14703062

3

Biotechnological and gene therapeutic strategies in cancer treatment.

Wels W, Moritz D, Schmidt M, Jeschke M, Hynes NE, Groner B. Wels W, et al. Among authors: schmidt m. Gene. 1995 Jun 14;159(1):73-80. doi: 10.1016/0378-1119(94)00786-r. Gene. 1995. PMID: 7607575

4

A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor.

Schmidt M, Hynes NE, Groner B, Wels W. Schmidt M, et al. Int J Cancer. 1996 Feb 8;65(4):538-46. doi: 10.1002/(SICI)1097-0215(19960208)65:4<538::AID-IJC24>3.0.CO;2-4. Int J Cancer. 1996. PMID: 8621240

5

Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.

Schmidt M, Wels W. Schmidt M, et al. Br J Cancer. 1996 Sep;74(6):853-62. doi: 10.1038/bjc.1996.448. Br J Cancer. 1996. PMID: 8826849 Free PMC article.

6

Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor.

Schmidt M, Vakalopoulou E, Schneider DW, Wels W. Schmidt M, et al. Br J Cancer. 1997;75(11):1575-84. doi: 10.1038/bjc.1997.270. Br J Cancer. 1997. PMID: 9184171 Free PMC article.

7

Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin.

Altenschmidt U, Schmidt M, Groner B, Wels W. Altenschmidt U, et al. Among authors: schmidt m. Int J Cancer. 1997 Sep 26;73(1):117-24. doi: 10.1002/(sici)1097-0215(19970926)73:1<117::aid-ijc18>3.0.co;2-d. Int J Cancer. 1997. PMID: 9334818

8

Purging of mammary carcinoma cells during ex vivo culture of CD34+ hematopoietic progenitor cells with recombinant immunotoxins.

Spyridonidis A, Schmidt M, Bernhardt W, Papadimitriou A, Azemar M, Wels W, Groner B, Henschler R. Spyridonidis A, et al. Among authors: schmidt m. Blood. 1998 Mar 1;91(5):1820-7. Blood. 1998. PMID: 9473251 Free article.

9

Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin.

Schmidt M, Reiser P, Hills D, Gullick WJ, Wels W. Schmidt M, et al. Int J Cancer. 1998 Mar 16;75(6):878-84. doi: 10.1002/(sici)1097-0215(19980316)75:6<878::aid-ijc10>3.0.co;2-#. Int J Cancer. 1998. PMID: 9506533

10

Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells.

Maurer-Gebhard M, Schmidt M, Azemar M, Altenschmidt U, Stöcklin E, Wels W, Groner B. Maurer-Gebhard M, et al. Among authors: schmidt m. Cancer Res. 1998 Jun 15;58(12):2661-6. Cancer Res. 1998. PMID: 9635594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,298 results

Search Page

Filters